Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2001, p. 2126-2128, Vol. 45, No. 7
Department of Pathology, University of
Alabama at Birmingham, Birmingham, Alabama
Received 18 September 2000/Returned for modification 5 February
2001/Accepted 9 April 2001
We determined in vitro activities of gatifloxacin and seven other
drugs against 100 isolates of Stenotrophomonas maltophilia using the agar gradient diffusion (Etest) method. Percentages of
susceptible isolates were as follows: trimethoprim-sulfamethoxazole, 90%; gatifloxacin, 71%; levofloxacin, 57%; ticarcillin-clavulanic acid, 54%; ceftazidime, 49%; ciprofloxacin, 29%; cefepime, 21%; and
piperacillin-tazobactam, 20%. Time-kill studies of three isolates indicated that gatifloxacin was bactericidal at times as early as
3 h of incubation when tested at concentrations equivalent to
twice the MIC (two isolates) and 4 times the MIC (one isolate).
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2126-2128.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Antimicrobial Activities of Gatifloxacin against Nosocomial
Isolates of Stenotrophomonas maltophilia Measured by MIC
and Time-Kill Studies
*
Corresponding author. Mailing address: Department of
Pathology, WP 230, 619 South 19th St., University of Alabama at
Birmingham, Birmingham, AL 35249. Phone: (205) 934-0578. Fax: (205)
975-4468. E-mail: waites{at}path.uab.edu.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»